| Literature DB >> 30808621 |
Florian Privé1, Hugues Aschard2, Michael G B Blum1.
Abstract
Polygenic Risk Scores (PRS) combine genotype information across many single-nucleotide polymorphisms (SNPs) to give a score reflecting the genetic risk of developing a disease. PRS might have a major impact on public health, possibly allowing for screening campaigns to identify high-genetic risk individuals for a given disease. The "Clumping+Thresholding" (C+T) approach is the most common method to derive PRS. C+T uses only univariate genome-wide association studies (GWAS) summary statistics, which makes it fast and easy to use. However, previous work showed that jointly estimating SNP effects for computing PRS has the potential to significantly improve the predictive performance of PRS as compared to C+T. In this paper, we present an efficient method for the joint estimation of SNP effects using individual-level data, allowing for practical application of penalized logistic regression (PLR) on modern datasets including hundreds of thousands of individuals. Moreover, our implementation of PLR directly includes automatic choices for hyper-parameters. We also provide an implementation of penalized linear regression for quantitative traits. We compare the performance of PLR, C+T and a derivation of random forests using both real and simulated data. Overall, we find that PLR achieves equal or higher predictive performance than C+T in most scenarios considered, while being scalable to biobank data. In particular, we find that improvement in predictive performance is more pronounced when there are few effects located in nearby genomic regions with correlated SNPs; for instance, in simulations, AUC values increase from 83% with the best prediction of C+T to 92.5% with PLR. We confirm these results in a data analysis of a case-control study for celiac disease where PLR and the standard C+T method achieve AUC values of 89% and of 82.5%. Applying penalized linear regression to 350,000 individuals of the UK Biobank, we predict height with a larger correlation than with the best prediction of C+T (∼65% instead of ∼55%), further demonstrating its scalability and strong predictive power, even for highly polygenic traits. Moreover, using 150,000 individuals of the UK Biobank, we are able to predict breast cancer better than C+T, fitting PLR in a few minutes only. In conclusion, this paper demonstrates the feasibility and relevance of using penalized regression for PRS computation when large individual-level datasets are available, thanks to the efficient implementation available in our R package bigstatsr.Entities:
Keywords: GenPred; LASSO; SNP; genomic prediction; polygenic risk scores; shared data resources
Mesh:
Year: 2019 PMID: 30808621 PMCID: PMC6499521 DOI: 10.1534/genetics.119.302019
Source DB: PubMed Journal: Genetics ISSN: 0016-6731 Impact factor: 4.562
Summary of all simulations
| Number of scenario | Dataset (number of SNPs) | Sample size of training set | Causal SNPs (number and location) | Distribution of effects | Heritability | Simulation model | Methods |
|---|---|---|---|---|---|---|---|
| 1 | All 22 chromosomes | 6000 | 30 in HLA | Gaussian | 0.5 | ADD | C+T |
| 30 in all | PLR | ||||||
| (281,122 SNPs) | 300 in all | Laplace | 0.8 | COMP | PLR3 | ||
| 3000 in all | (T-Trees) |
Parameters are the same as the ones in the upper box.
Figure 1Main comparison of C+T and PLR when simulating phenotypes with additive effects (scenario N°1, model “ADD”). Mean AUC over 100 simulations for PLR and the maximum AUC reported with “C+T-max” (clumping threshold at ). Upper (lower) panels present results for effects following a Gaussian (Laplace) distribution, and left (right) panels present results for a heritability of 0.5 (0.8). Error bars are representing of nonparametric bootstrap of the mean AUC. The blue dotted line represents the maximum achievable AUC.
Figure 3Comparison of methods when simulating 300 causal SNPs with additive effects and when varying sample size (scenario N°3). Mean AUC over 100 simulations for the maximum values of C+T for three different thresholds (0.05, 0.2, and 0.8) and PLR as a function of the training size. Upper (lower) panels are presenting results for effects following a Gaussian (Laplace) distribution and left (right) panels are presenting results for a heritability of 0.5 (0.8). Error bars represent of nonparametric bootstrap of the mean AUC. The blue dotted line represents the maximum achievable AUC.
Figure 2Comparison of methods when simulating phenotypes with additive effects and using chromosome six only (scenario N°2). Thinner lines represent results in scenario N°1. Mean AUC over 100 simulations for PLR and the maximum values of C+T for three different thresholds (0.05, 0.2, and 0.8) as a function of the number and location of causal SNPs. Upper (lower) panels present results for effects following a Gaussian (Laplace) distribution and left (right) panels present results for a heritability of 0.5 (0.8). Error bars representing of nonparametric bootstrap of the mean AUC. The blue dotted line represents the maximum achievable AUC.
Results for the real celiac dataset
| Method | AUC | pAUC | # predictors | Execution time (s) |
|---|---|---|---|---|
| C+T-max | 0.825 (0.000664) | 0.0289 (0.000187) | 8360 (744) | 130 (0.143) |
| PLR | 0.887 (0.00061) | 0.0411 (0.000224) | 1570 (46.4) | 190 (1.21) |
| PLR3 | 0.891 (0.000628) | 0.0426 (0.000219) | 2260 (56.1) | 296 (2.03) |
The results are averaged over 100 runs where the training step is randomly composed of 12,000 individuals. In the parentheses is reported the SD of bootstrap samples of the mean of the corresponding variable. Results are reported with three significant digits.
Results for the UK Biobank
| Trait | Method | # Predictors | Execution time | |
|---|---|---|---|---|
| Height | PLR | 0.656/0.657 | 115,997 | 21 hr |
| Height | C+T-max | 0.549/0.561 | 45,570 | 69 min |
The sizes of training/test sets for height (resp. breast cancer) are 350,000/24,131 (resp. 150,000/38,628). For height, r (correlation between predicted and true heights) is reported within women/men separately; for breast cancer, AUC is reported.